Cargando…
Effect of concurrent use of anti-retroviral therapy and levonorgestrel sub-dermal implant for contraception on CD4 counts: a prospective cohort study in Kenya
INTRODUCTION: Simultaneous use of contraceptive hormones and anti-retroviral therapy (ART) may theoretically lessen the effectiveness of both. Women on ART need assurance that hormonal contraception is safe and effective. The sub-dermal implant is an ideal product to study: low and steady progestin...
Autores principales: | Hubacher, David, Liku, Jennifer, Kiarie, James, Rakwar, Joel, Muiruri, Peter, Omwenga, Jackline, Chen, Pai-Lien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International AIDS Society
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586663/ https://www.ncbi.nlm.nih.gov/pubmed/23458102 http://dx.doi.org/10.7448/IAS.16.1.18448 |
Ejemplares similares
-
Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a
sub-dermal contraceptive implant
por: Scarsi, Kimberly, et al.
Publicado: (2014) -
Introduction of the levonorgestrel intrauterine system in Kenya through mobile outreach: review of service statistics and provider perspectives
por: Hubacher, David, et al.
Publicado: (2014) -
The Levonorgestrel Intrauterine System: Reasons to Expand Access to the Public Sector of Africa
por: Hubacher, David
Publicado: (2015) -
Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant
por: Ali, Moazzam, et al.
Publicado: (2016) -
Levonorgestrel intrauterine system associated amenorrhea: a systematic review and metaanalysis
por: Sergison, Jill E., et al.
Publicado: (2019)